Publicaciones en las que colabora con Mª Jesús Grilló Dolset (25)

2021

  1. Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle

    PLoS ONE, Vol. 16, Núm. 11 November

2019

  1. GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep

    Transboundary and Emerging Diseases, Vol. 66, Núm. 1, pp. 505-516

2018

  1. Identification of lptA, lpxE, and lpxO, three genes involved in the remodeling of Brucella cell envelope

    Frontiers in Microbiology, Vol. 8, Núm. JAN

2015

  1. Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 5, pp. 2700-2712

2014

  1. Brucella abortus depends on pyruvate phosphate dikinase and malic enzyme but not on fbp and glpX fructose-1,6-bisphosphatases for full virulence in laboratory models

    Journal of Bacteriology, Vol. 196, Núm. 16, pp. 3045-3057

  2. Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice

    Veterinary Research, Vol. 45, Núm. 1

  3. The identification of wadB, a new glycosyltransferase gene, confirms the branched structure and the role in virulence of the lipopolysaccharide core of Brucella abortus

    Microbial Pathogenesis, Vol. 73, Núm. 1, pp. 53-59

2013

  1. Lipopolysaccharide as a target for brucellosis vaccine design

    Microbial Pathogenesis, Vol. 58, pp. 29-34

2012

  1. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition

    PLoS Pathogens, Vol. 8, Núm. 5

2011

  1. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen- associated molecular pattern

    PLoS ONE, Vol. 6, Núm. 1

2010

  1. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams

    Vaccine, Vol. 28, Núm. 17, pp. 3038-3046

2009

  1. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria

    Vaccine, Vol. 27, Núm. 17, pp. 2379-2386

2008

  1. Brucellosis vaccines: Assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence

    Infection and Immunity, Vol. 75, Núm. 10, pp. 4867-4874

2006

  1. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams

    Vaccine, Vol. 24, Núm. 11, pp. 1897-1905

  2. Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice

    Veterinary Microbiology, Vol. 118, Núm. 1-2, pp. 124-132

  3. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice

    Vaccine, Vol. 24, Núm. 19, pp. 4179-4187

  4. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants

    Vaccine, Vol. 24, Núm. 15, pp. 2910-2916

  5. Synthesis of phosphatidylcholine, a typical eukaryotic phospholipid, is necessary for full virulence of the intracellular bacterial parasite Brucella abortus

    Cellular Microbiology, Vol. 8, Núm. 8, pp. 1322-1335

2004

  1. Rough vaccines in animal brucellosis: Structural and genetic basis and present status

    Veterinary Research, Vol. 35, Núm. 1, pp. 1-38